Amid market resilience, Deven Choksey anticipates Nifty potentially reaching 25,200, with corrections offering buying opportunities. He suggests IT, pharmaceuticals, and metals could drive market momentum, favoring large-cap stocks over mid and small-caps. Controlled input costs and improved capital goods demand may benefit manufacturing, with selective buying advised in IT and pharma stocks.